Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Health Behaviour Change

- PMLiVE

If a nudge doesn’t last forever, how do we ensure sustained behaviour change?

Changing behaviour isn’t easy, but maintaining behaviour change is even harder.We know that by the tiny number of New Year’s resolutions we actually manage to keep, the number of gym...

AstraZeneca AZ

AZ severe asthma drug benralizumab backed by CHMP

The IL-5 inhibitor set for European approval to treat severe eosinophilic asthma

- PMLiVE

Dynavax receives FDA green light for hepatitis B vaccine

Heplisav-B becomes first and only two-dose hep B vaccine approved in the US

- PMLiVE

Ex-GSK head Witty to head group overseeing UK fast-track scheme

Medicines selected for the AAP could be made available much earlier

- PMLiVE

Good Relations appoints new executive director

Sophie Taylor-Roberts will head the agency’s health and wellbeing practice

- PMLiVE

Lucid launches rare and specialist disease agency

Vivid MedComms will be headed by Alison Cantle

IFPMA names new communications director

Helen Gallagher joins the association from Ferring Pharmaceuticals

European venture funding for the life science sector

Trends in healthcare

- PMLiVE

Effective sales performance

The role of targeting

- PMLiVE

Transforming Access to Medicines Through Patient-Centric Solutions

As medicines access evolves and pharmaceutical companies take an increasingly nuanced approach to it, it’s ever-more important to focus on particular aspects of this area and investigate whether firms are...

Prime Global expands Core’s senior team

Norbert Brunhuber joins as director of client services

Sanofi reception

Sanofi licences Principia MS drug in $805m deal

Californian biotech is set to receive $765m plus in milestone payments if PRN2246 goes to market

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links